Acelyrin Inc (SLRN)
4.385
-0.24
(-5.29%)
USD |
NASDAQ |
May 17, 16:00
4.385
0.00 (0.00%)
After-Hours: 20:00
Acelyrin Market Cap: 434.73M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 434.73M |
| May 16, 2024 | 458.50M |
| May 15, 2024 | 469.39M |
| May 14, 2024 | 468.40M |
| May 13, 2024 | 464.44M |
| May 10, 2024 | 463.45M |
| May 09, 2024 | 483.25M |
| May 08, 2024 | 474.34M |
| May 07, 2024 | 456.98M |
| May 06, 2024 | 432.25M |
| May 03, 2024 | 430.27M |
| May 02, 2024 | 420.38M |
| May 01, 2024 | 420.38M |
| April 30, 2024 | 413.46M |
| April 29, 2024 | 419.39M |
| April 26, 2024 | 419.39M |
| April 25, 2024 | 419.39M |
| April 24, 2024 | 452.03M |
| April 23, 2024 | 455.00M |
| April 22, 2024 | 476.76M |
| April 19, 2024 | 495.55M |
| April 18, 2024 | 482.70M |
| April 17, 2024 | 496.54M |
| April 16, 2024 | 508.41M |
| April 15, 2024 | 546.00M |
| Date | Value |
|---|---|
| April 12, 2024 | 531.16M |
| April 11, 2024 | 569.74M |
| April 10, 2024 | 563.80M |
| April 09, 2024 | 588.53M |
| April 08, 2024 | 598.42M |
| April 05, 2024 | 600.38M |
| April 04, 2024 | 632.03M |
| April 03, 2024 | 655.77M |
| April 02, 2024 | 646.87M |
| April 01, 2024 | 658.74M |
| March 28, 2024 | 663.96M |
| March 27, 2024 | 663.96M |
| March 26, 2024 | 654.13M |
| March 25, 2024 | 662.98M |
| March 22, 2024 | 677.72M |
| March 21, 2024 | 761.40M |
| March 20, 2024 | 814.24M |
| March 19, 2024 | 779.01M |
| March 18, 2024 | 745.74M |
| March 15, 2024 | 767.27M |
| March 14, 2024 | 770.20M |
| March 13, 2024 | 806.42M |
| March 12, 2024 | 811.31M |
| March 11, 2024 | 812.29M |
| March 08, 2024 | 732.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
413.46M
Minimum
Apr 30 2024
2.802B
Maximum
Aug 22 2023
1.237B
Average
866.32M
Median
Nov 14 2023
Market Cap Benchmarks
| Lexicon Pharmaceuticals Inc | 639.84M |
| Eagle Pharmaceuticals Inc | 61.82M |
| Avalo Therapeutics Inc | 9.917M |
| Design Therapeutics Inc | 249.14M |
| CEL-SCI Corp | 68.78M |
Market Cap Related Metrics
| Price to Book Value | 0.675 |
| Price | 4.385 |
| Earnings Yield | -54.21% |